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Abstract
Background: Healthcare-acquired infections by pathogenic microorganisms including viruses represent significant
health concern worldwide. Next to direct transmission from person-to-person also indirect transmission from
contaminated surfaces is well documented and important route of infections. Here, we tested antiviral properties
of hybrid coating containing silver, copper and zinc cations that was previously shown to be effective against
pathogenic bacteria including methicillin-resistant Staphylococcus aureus. Hybrid coatings containing silver, copper and
zinc cations were prepared through radical polymerization via sol-gel method and applied on glass slides or into the
wells of polymethylmethacrylate plates. A 10 μl droplet of several viruses such as human immunodeficiency virus type
1 (HIV-1), influenza, dengue virus, herpes simplex virus, and coxsackievirus was added to coated and uncoated slides or
plates, incubated usually from 5 to 240 min and followed by titer determination of recovered virus.
Results: Scanning electron microscopy analysis showed better adhesion of coatings on glass surfaces, which resulted
in 99.5–100 % HIV-1 titer reduction (3.1 ± 0.8 log10TCID50, n = 3) already after 20 min of exposure to coatings, than on
coated polymethylmethacrylate plates with 75–100 % (1.7 ± 1.1 log10TCID50, n = 3) and 98–100 % (2.3 ± 0.5 log10TCID50,
n = 3) HIV-1 titer reduction after 20 and 120 min of exposure, respectively. Slower virucidal kinetics was observed with
other enveloped viruses, where 240 min exposure to coated slides lead to 97 % (dengue), 100 % (herpes simplex) and
77 % (influenza) reduction in virus titers. Interestingly, only marginal reduction in viral titer after 240 min of exposure
was noticed for non-enveloped coxsackie B3 virus.
Conclusions: Our hybrid coatings showed virucidal activity against HIV and other enveloped viruses thus providing
further findings towards development of broad-spectrum antimicrobial coating suitable for surfaces in healthcare settings.
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Background
Healthcare–associated infections (HAIs) by pathogenic
bacteria, viruses and other microorganisms constitute
significant cause of morbidity and mortality worldwide.
Although exact statistical data are lacking, 1.7 million
HAIs were estimated to occur in 2002 in U.S. hospitals
alone [1]. More recent survey indicates that everyday
approximately 1 of every 25 patients in U.S. acute care
hospitals has at least one HAI [2]. Next to direct transmis-
sion from person-to-person indirect transmission from
contaminated surfaces is also well documented and im-
portant route of infections. Self-decontaminating surfaces
would represent additional safety measure towards pre-
venting transmission in healthcare settings. In recent years
a growing interest is seen in the use of organic-inorganic
hybrid materials in medicine, for example antibacterial
protective coatings applied on number of devices used in
healthcare [3–7], micro and/or nano needles for transder-
mal drug delivery [8], antibacterial protective coatings on
the surface of artificial joints [9], or dental implants [10].
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Hybrid materials are very conveniently prepared by
sol-gel method, which can be briefly described as a special
process of glass and ceramics manufacture at room or
slightly elevated temperature. This technique became an
independent and a very comprehensive discipline, docu-
mented by numerous books [11–15] and reviews [16, 17].
With the introduction of organically-modified silicates
(ORMOSILs) the sol-gel products started to be an interest-
ing precursor for number of hybrid materials applicable in
medicine. Specifically 3-(trimethoxysilyl)propyl methacryl-
ate (TMSPM) either in the pure form or in addition to tet-
rafunctional silica precursors such as tetraethylorthosilicate
(TEOS) or tetramethylorthosilicate (TMOS) allows large
variations in optical, mechanical and chemical properties
and can be tailored for specific uses [18, 19]. In addition,
the sol-gel process allows the encapsulation of different
nanoparticles with known antimicrobial activity e.g. metal-
lic nanoparticles such as Ag, Cu, Zn, Au etc. [4, 20].
From metal nanomaterials with biocidal properties,
silver and copper received the most attention. Next to
well documented bactericidal activities both silver and
copper showed potent virucidal properties [21]. Several
studies have confirmed anti-HIV activity of silver nanopar-
ticles [22–24] inhibiting most likely entry step by binding
directly with gp120 [25]. Furthermore, silver nanoparticles
were shown to inhibit herpes simplex virus type 1 [26]
and 2 [27], vaccinia virus [28], respiratory syncytial virus
[29], influenza A [30], tacaribe virus [31] and hepatitis B
virus [32].
Virucidal activity of copper in the form of copper oxide
was evaluated in variety of materials such as fibers, latex,
filter matrices and other polymeric materials [33, 34]. Cop-
per oxide-containing filters effectively neutralized HIV-1 in
medium and breastmilk and reduced cell-associated HIV
in dose-dependent manner [35, 36]. In addition, these
filters reduced infectious viral titers of several DNA and
RNA viruses, among others yellow fever virus, influenza A
virus, measles virus, respiratory syncytial virus, adenovirus
type 1 and cytomegalovirus [37]. Recently, it was shown
that cuprous compounds deactivate more efficiently bacte-
riophages and bacteria than cupric compounds [38].
Photoactivation of titanium dioxide by UV generates
reactive oxygen molecules on the surface of TiO2 and has
been shown to effectively inactivate influenza A virus [39],
HIV-1 [40], and murine norovirus [40, 41]. Halogen and
interhalogen TiO2 nanoparticles, except for chlorinated
adduct, completely inactivated bacteriophages MS-2, ψ-
X174 and PRD-1, showing that oxidizing potential can be
generated without UV photoactivation [42]. Similarly, metal
oxide nanoparticles, CeO2 and Al2O3, and their halogen
adducts exhibited excellent virucidal activities against
bacteriophages.
In addition to virucidal metal nanoparticles, polymeric
coatings with antiviral activities were reported. Coatings
based on hydrophobic polycations N,N-dodecyl methyl-
polyethylenimine on a glass slide lowered influenza
infectious titer by at least four fold [43]. Similarly, up to
five fold reduction of influenza infectious virus titer was
achieved with hyperbranched polymers with quaternary
ammonium on glass surfaces, while no significant reduc-
tion of infectious poliovirus was detected [44].
Recently, we have reported on new type of hybrid
coating containing silver and copper cations with strong
antibacterial effect against variety of commonly occur-
ring bacteria in hospital including Staphylococcus aureus
and its methicillin-resistant variant [6]. Here, we have
tested antiviral properties of this type of hybrid coating.
Methods
Chemicals
Tetraethylorthosilicate (TEOS, Sigma-Aldrich, 98 wt.%),
3-(trimethoxysilyl)propyl methacrylate (TMSPM, Sigma–
Aldrich, 98 wt.%), methylmethacrylate (MMA, Sigma-
Aldrich, 99 wt.%), dibenzoylperoxide (BPO, Luperox® A75,
Sigma-Aldrich, 75 wt.% and 25 wt.% of water for
stabilisation), titanium isopropoxide (IPTI, Sigma-Al-
drich >97 wt.%), silver nitrate (AgNO3, Sigma-Aldrich,
99.8 wt.%), copper nitrate trihydrate (Cu(NO3)2.3H2O,
Sigma-Aldrich, 98–103 wt.%), zinc nitrate hexahydrate
(Zn(NO3)2.6H2O, Sigma-Aldrich, 98 wt.%), propan-2-ol
(Penta CZ, p.a. 99.98 wt.%), nitric acid (HNO3, Lach:ner
CZ, p.a. 65 wt.%), distilled water, photoinitiator Irgacure
819 (Ciba CZ, 45 wt.%). Substrates used for preparation of
hybrid coatings; glass covering, size 18 × 18 mm with
thickness 0.13 – 0.17 mm, (INTRACO MICRO, CZ);
poly(methyl methacrylate) – Cell Culture Plates (PMMA),
size 75 × 125 × 15 mm, (Corning Incorporated NY,
Costar, USA).
Sol synthesis
Silver nitrate (0.12 g, 0.71 mmol) was dissolved in 26 ml
of propan-2-ol by stirring at room temperature for
60 min. Subsequently, TEOS (1.9 ml, 8.51 mmol), TMSPM
(1.0 ml, 4.21 mmol), MMA (0.9 ml, 8.41 mmol) and BPO
(0.1 g, 0.41 mmol) were added via septum into the flask
and the reaction mixture was stirred under the atmosphere
of nitrogen at room temperature until all of the BPO dis-
solved. After that, 0.2 ml of a 2 M solution of nitric acid,
distilled water (0.4 ml, 22 mmol), copper nitrate trihydrate
(0.1 g, 0.40 mmol) and zinc nitrate hexahydrate (0.11 g,
0.37 mmol) were dissolved in 26 ml of propan-2-ol in a
separate flask and this solution was added to the sol and
stirred intensively at room temperature.
Finally, IPTI (0.6 ml, 2.22 mmol) was added and the
reaction mixture was stirred for another 15 min at room
temperature. The resulting sol was heated to reflux in an
oil bath while being stirred for 35 min, then cooled
down to room temperature and stored in a polyethylene
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bottle in the dark at 20 °C. A sol prepared in this man-
ner was used within three weeks.
Preparation of substrates for application of coatings
Glass samples were mechanically cleaned with a com-
mercial detergent (Jar), then rinsed with distilled water,
sonicated in the same medium in an ultrasound bath for
5 min and rinsed with distilled water. Then, they were
immersed in nitric acid diluted 1:1 with distilled water
for three min, repeatedly rinsed with distilled water and
finally with propan-2-ol. The cleaned substrates were
stored in propan-2-ol. PMMA samples were washed
with a commercial detergent (Jar), then rinsed with dis-
tilled water several times and immediately immersed in
propan-2-ol in an ultrasound bath for 5 min. Finally,
they were rinsed with propan-2-ol and stored in it.
Coating procedures
Dip-coating
The glass substrates were dipped into sol, then were
withdrawn at a speed of 4 cm.min-1.
Flow-coating
The sol diluted with 1 % solution of the photoinitiator
Irgacure 819 (BASF, Switzerland) in molar ratio 1:1
(300 μl) was dropped into wells in PMMA plates by cali-
brated pipette (V = 300 μl). The solution was left in the
wells for 30 s, and subsequently was removed by the
same pipette from each well.
Curing
The coatings on glass were left for 60 min at room
temperature, then were cured for 3 h at 150 °C. The
coatings on PMMA plates were left for 60 min at room
temperature, then were cured for 1 h at UV-A (315–
400 nm, Philips Actinic BL 15 W, made in Holland). The
distance of fluorescent lamp from samples was 30 cm.
Measuring properties of coatings
FT- IR spectroscopy
The measurements of reflective IR spectra were per-
formed on an FT-IR spectrometer Nicolet™ iSTM10
(Thermo Scientific™) at room temperature (25 °C). The
spectrometer was used with the extension method ATR
crystal Ge. For liquid samples, the measurements were
performed after evaporation of the solvent. The solid
samples were measured on a thin layer of aluminum foil.
Surface morphology – scanning electron microscopy
The quality and morphology of the hybrid coatings was
measured through Scanning Electron microscope Carl
Zeiss ULTRA Plus with micro-analytic fragment EDS
system Silicon Drift Detector 20 mm2 (SDD) - X-you
max (OXFORD Instruments). The transparent samples
(magnified 1120x and 18280x) were gold-dusted 3 nm
through QR150R (Quorum Technologies) with ion evap-
oration system model 1060 SEM Mill (Fischione) and
observed (through the In-Lens detector) in the form of
secondary electrons SE1.
Cells and viruses
All cells were mycoplasma negative (routinely tested at
Generi Biotech, Czech Republic) and cultured in tissue-
culture treated polystyrene plates in 5 % CO2 and at 37 °C.
TZM-bl cells (Dr. John C. Kappes, Dr. Xiaoyun Wu and
Tranzyme Inc.) and HeLa cells (Dr. Richard Axel) were
obtained through the NIH AIDS Reagent Program,
Division of AIDS, NIAID, NIH. Madin-Darby canine
kidney cells (MDCK) and HB-46 cells were obtained
from the American Type Culture Collection (ATCC,
Manassas, VA), Vero cells from the European Collec-
tion of Cell Cultures and HEK293T cells from Stanford
University (Stanford, CA). All cells were maintained in
DMEM with L-glutamine, 10 % fetal bovine serum
(FBS), 100 U of penicillin/ml and 100 μg of streptomycin/
ml (all Sigma-Aldrich, St. Louis, MO). Virus HIV-1NL4-3
was prepared by transfection of plasmid pNL4-3, obtained
through the NIH AIDS Reagent Program, Division of
AIDS, NIAID, NIH from Dr. Malcolm Martin, into
HEK293T cells and after 48 h supernatant was harvested,
filtered through 0.45 μm steri-flip, aliquoted and stored
at -80 °C. Human coxsackie B3 virus (strain Nancy) and
human herpesvirus 1 (strain HF) were obtained from
ATCC, influenza virus H1N1 A/Mexico/4108/2009 from
Diagnostic Hybrids (Athens, OH) and dengue virus type 2
from Dr. Jochen Bodem, University of Wurzburg
(Wurzburg, Germany).
Experimental setup for determination of virucidal activity
Cover glass experiments
Coated or uncoated (in control experiment) 18 × 18 mm
cover glasses were placed into 6-well plate and 10 μl
droplet of 1.66 × 105 50 % tissue cell culture infectious
doses (TCID50)/ml of HIV-1 or 3.63 × 10
5 TCID50/ml of
influenza A/H1N1 virus or 3.98 × 106 TCID50/ml of
dengue virus type 2 virus or 1.00 × 106 TCID50/ml of
herpes simplex type 1 virus (HSV-1), or 3.16 24 × 104
TCID50/ml of coxsackie B3 virus was applied in the cen-
ter of the glass. The droplet was immediately covered by
uncoated cover glass to spread the virus on the whole
area. After incubation at specified time usually 5, 10, 20,
30, 60, 120, and 240 min, 490 μl of 1X phosphate buff-
ered saline (PBS) was added to the coverslips, the top
coverslip was lifted and the virus-exposed sides of both
coverslips were washed by pipetting 3 times. We col-
lected the whole washing and used for titer determin-
ation. Experiments were performed with three cover
glasses for each time point. All virus titer determinations
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of recovered virus were performed with 11 twofold dilu-
tions in triplicate according to the type of virus as men-
tioned below and virus titer reduction was expressed in
percentage or plotted as TCID50 [IU/ml] versus time.
Experiments with 96-well plates
Virus droplet (10 μl) of 1.66 × 105 TCID50/ml of HIV-1
was placed in the center of wells (coated with photopo-
lymerization and uncoated) in 96-well plate and covered
with lid. At 2, 5, 10, 20, 30, 60, and 120 min 90 μl of 1X
PBS was added to the well, mixed three times by pipet-
ting up and down and removed from the well. All exper-
iments in 96-well plates were performed in triplicate.
Recovered virus was immediately titrated according the
protocols mentioned below and virus titer reduction was
expressed in percentage.
Titer determination
The determination of all virus titers were performed in
triplicate from twofold serial virus dilutions and calcu-
lated according the method by Reed and Muench [45].
Methods for the discrimination of infected and unin-
fected wells were virus specific and are described below.
HIV titer determination
TZM-bl indicator cell line was used to quantitate HIV
titers [46]. Twofold serial dilutions of HIV were added
in triplicate to 30,000 TZM-bl cells plated 24 h before in
DMEM with L-glutamine, 10 % fetal bovine serum, 100
U of penicillin/ml and 100 μg of streptomycin/ml. After
48 h incubation at 37 °C in 5 % CO2, the supernatant
was removed, cells washed with 1X PBS, fixed with 1 %
glutaraldehyde and incubated with X-galactosidase stain-
ing solution. After 2 h of incubation infected wells that de-
veloped blue loci were counted as positive. Alternatively,
after 48 h of incubation the firefly luciferase luminescent
assay was performed and luminescence was measured in
Victor X3 plate reader (Perkin Elmer, Waltham, MA).
Wells with relative light units above background (mean of
luminescence of negative wells plus two standard devia-
tions) were considered positive.
Dengue virus titer determination
Immunofluorescence staining was used to visualize in-
fected cells [47]. Briefly, twofold serial dilutions of den-
gue virus type 2 were added in triplicate to 20,000 Vero
cells plated day before in DMEM with 2 % fetal bovine
serum, 100 U of penicillin/ml and 100 μg of strepto-
mycin/ml. After 72 h of incubation at 37 °C in 5 % CO2,
cells were fixed with 4 % paraformaldehyde and perme-
abilized with 0.2 % Triton X-100. Then, cells were
washed with 1X PBS and incubated overnight at 4 °C
with dengue virus type 2 serotype-specific mouse mono-
clonal antibody, which was harvested from HB-46 cells.
Wells were washed three times with 1X PBS, incubated
90 min with Cy3-labeled donkey anti mouse IgG (Jackson
Immunoresearch Europe) and documented using fluores-
cence microscope Olympus IX-81 with camera (Hamburg,
Germany). ImageJ software (NIH) was used for image
analysis and evaluation of positive and negative wells.
Influenza virus titer determination
Immuno-stained plaque assay using low-viscosity overlay
medium developed by Matrosovich et al. [48] was
adapted for influenza virus determination. Day before
25,000 MDCK cells were plated in DMEM medium with
10 % FBS. Following day cells were washed twice with
1X PBS, replenished with DMEM medium without FBS
and twofold serial dilutions of influenza virus were
added to the cells. After 1 h of incubation the cells and
virus mixture was overlaid with 1:1 mixture of 2.4 %
Avicel RC/CL (FMC Biopolymer, Philadelphia, PA) and
DMEM without FBS, with 7.5 % bovine serum albumine,
0.5 μg/ml TPCK-trypsin (both from Sigma-Aldrich), 100
U of penicillin/ml and 100 μg of streptomycin/ml. After
one day of incubation in 37 °C in 5 % CO2, the avicel
solution was removed from the wells, the cells were
washed with 1X PBS, fixed with 4 % paraformaldehyde,
permeabilized with 20 mM glycine/0.5 % Triton X-100
for 20 min and incubated for 1 h with 1:2500 dilution
of monoclonal influenza A antibody against nucleocap-
sid (Merck Millipore, Darmstadt, Germany) in 10 %
normal horse serum and 0.05 % Tween 80 (both Sigma-
Aldrich). Mouse secondary antibody (1:5000 dilution)
in 10 % normal horse serum and 0.05 % Tween 80 was
applied for 1 h and followed by 30 min of incubation in
TrueBlue (KPL, Gaithersburg, MA) until blue plaques
developed in infected wells.
Herpes simplex and coxsackie virus titer determination
Twofold serial dilutions of herpes simplex and cox-
sackie B3 virus were added to 20,000 Vero cells and
30,000 HeLa cells, respectively. Both cell lines were
plated day before in DMEM with 10 % FBS and follow-
ing day the medium was replaced with serum-reduced
DMEM with 2 % FBS. After 1 h of incubation, the cells
and virus mixture was overlaid with 1:1 mixture of
2.4 % Avicel RC/CL and DMEM with 2 % FBS. After
three days of incubation in 37 °C in 5 % CO2 the same
procedure was followed as with influenza titer deter-
mination with following changes in the virus specific
antibody dilutions. HSV-1 infected cells were incubated
with 1:800 dilution of anti-HSV type I and II monoclo-
nal antibody and coxsackievirus-infected cells were in-
cubated with 1:1000 dilution of anti-coxsackievirus B3
antibody (both Merck Millipore, Darmstadt, Germany).
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Measurement of cytotoxicity of antiviral coatings
Six uncoated and twelve coated glass covers (half of the
covers were prepared by photopolymerization and half
were polymerized by heat) were incubated with 500 μl of
1X PBS for 15 sec and for 4 h. After incubation, 50 μl of
liquid were transferred in triplicate on HeLa and Vero
cells, incubated for 72 h and cytotoxic effect was ana-
lyzed by XTT colorimetric assay. Briefly, 50 μl of 50:1
mixture of XTT labeling reagent (1 mg/ml) and PMS
electron-coupling reagent (0.383 mg/ml) was added to
the wells and incubated for 4 h in 37 °C in 5 % CO2.
Formation of orange formazan dye was measured in
Victor X3 plate reader and wells with absorbance lower
than cutoff that was calculated as mean of absorbance
of wells without virus plus two standard deviations were
considered infected.
Statistical analysis
Data were analyzed using a one-way analysis of variance
test and followed by the Bonferroni’s multiple comparison
test. All differences with a p-value less than 0.05 were con-
sidered statistically significant. Statistical analyses were per-




Figure 1 shows the FT-IR spectra of the organic-
inorganic sol obtained from the combination of TEOS,
TMSPM, MMA, and IPTI in the presence of BPO.
The characteristic stretching vibration peaks of -C = O
(type 1 and type 2) occurred at 1660 – 1740 cm-1 for
type 1, and 1655 – 1750 cm-1 for type 2. The infrared
absorption of bimodal frequency distribution occurred
due to the conjugation effect between -C = O and
nearby -C = C- and hydrogen bonds. The characteristic
stretching vibration peak of -C = C- occurred at 1633 cm−1
and the characteristic stretching vibration peak of BPO ini-
tiator occured at 1787 - 1767 cm-1. In Fig. 1 the progress
of free radical polymerization of acrylates is visible (see also
Table 1). The conjugated -C = C-C =O group is gradually
transformed into -C-C-C = O and this change is acom-
panied by weakening of -C = C- band. At the same time
the -C = O of BPO is weakening as well as this com-
pound gradually decomposes. It confirms that TMSPM
and MMA molecules were bound together and most
likely also grafted on the SiO2 in the process of TEOS
and TMSPM co-hydrolysis.
Surface morphology obtained through SEM
The surfaces of hybrid coatings were analyzed using SEM
on two types of substrates; PMMA plates (Fig. 2a, b) and
glass (Fig. 3a, b). It confirmed that the hybrid coatings
almost precisely copied the surface of the substrates
(Fig. 2 and 3).
We observed a number of clearly visible pores in size
of few nm on the coated PMMA sample (Fig. 2b), in
contrary to that on the coated glass sample, where the
number of pores was lower. This can be attributed to
the different type of polymerization used. The photopoly-
merization with photoinitiator Irgacure 819 was used for
coating PMMA samples via UV-A (range 315–400 nm). It
was dictated by temperature sensitivity of PMMA that is
not stable at temperature higher than 60 °C. The glass
samples, however, were polymerized by heating for 3 h
at 150 °C. The hybrid coating on the glass substrate
(Fig. 3a, b) showed excellent adhesion to the surface.























Fig. 1 FT-IR; polymerization of the sol. Sampling in different time intervals (1- 5 min of sol reflux; 2 – 10 min of sol reflux; 3 – 15 min of sol reflux;
4 – 20 min of sol reflux; 5 – 25 min of sol reflux; 6 – 35 min of sol reflux)
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was much weaker which might be improved by plasma
treatment of PMMA surface prior coating.
Cytotoxicity of hybrid coatings to Vero and HeLa cells
The cytotoxicity of washings from hybrid coatings with
silver, copper and zinc prepared by heat and photopoly-
merization were evaluated in Vero and HeLa cell lines at
two time points (Fig. 4) Immediate cytotoxic effect was
assessed after 15 sec exposure to coated glass and re-
sulted in no loss of viability of Vero cells and only small
(2–5 %) loss of viability of HeLa cells. Even exposure
for four hours did not release any significant toxic material
from coated glass coverslips, which is demonstrated by the
viability values above 90 % for both cell lines and both
polymerization methods. The lowest viability was observed
with hybrid coatings prepared by heat polymerization with
95 % viability for Vero cells and 91 % viability for HeLa
cells when compared to the viability of washings from un-
coated glass slides after 15 sec exposure.
Anti-HIV-1 activity of hybrid coatings on glass slides
As a first step in evaluating the virucidal activity of
hybrid coatings we coated six glass coverslips by heat
polymerization, six by photopolymerization and six
were left uncoated. We applied 10 μl of HIV-1 on the
coverslip and incubated three coverslips for 5 min and
three coverslips for 20 min. The Table 2 displays recovered
HIV-1 titer after washing with 0.49 ml of 1X PBS for each
coverslip. We found no statistically significant difference in
HIV-1 viability between 5 and 20 min exposure of HIV-1
to uncoated glass coverslips with HIV-1 titers of 3981
TCID50/ml and 2987 ± 1721 TCID50/ml, respectively.
Moreover, recovered virus titer approximately matched ini-
tial input of HIV-1 (3320 TCID50/ml) after similar dilution
in 0.49 ml of PBS without exposure to the uncoated glass
coverslip. Decrease in HIV-1 titer was already noticeable
after 5 min exposure to hybrid coatings. The decrease was
smaller in the case of glass coverslips with hybrid coatings
prepared by heat polymerization with 79 % HIV-1 titer re-
duction on average, than in the case of glass coverslips with
hybrid coatings prepared by photopolymerization where
the reduction was 98 %. Similarly, 20 min exposure of
HIV-1 on glass coverslips with hybrid coatings prepared by
photopolymerization exhibited better virucidal activity that
resulted in 100 % inactivation of HIV-1 on two out of three
coverslips than coverslips coated by heat polymerization
where 10 % of residual HIV-1 activity remained.
HIV-1 inactivation on coated PMMA surface
Next we examined the anti-HIV-1 activity of hybrid
coating when applied on poly(methyl methacrylate)
surface. Figure 5 summarizes results from three separate
experiments each performed in triplicate. We can see
quick virucidal effect in first 5 min followed by slower
additional virucidal effect during the span of 2 h. Inter-
estingly, complete virucidal efficiency was achieved in
only one out of three experiments. Nevertheless, at least
98 % reduction of HIV-1 titer was obtained after 2 h of
exposure to coated PMMA wells.
Effect of hybrid coatings against other viruses
To assess the virucidal potential of hybrid coatings
against other enveloped, nonenveloped, RNA and DNA
viruses we selected dengue virus, coxsackievirus, influ-
enza virus and herpes simplex virus. Droplet of 10 μl of
Table 1 FT-IR; a polymerization of the sol used for the preparation
of hybrid coatings
Sample Time Stretching vibrations of C = O and C = C groups
1 5 min reflux 1787 – 1767 cm-1 stretching vibration
-C = O bonds (BPO)
1660 – 1740 cm-1 stretching vibration
-C = O bonds, type 1 (MMA)
1655 – 1750 cm-1 stretching vibration
-C = O bonds, type 2 (propionate)
1633 cm-1 stretching vibration -C = C- bonds
2 10 min reflux
3 15 min reflux
4 20 min reflux
5 25 min reflux
6 35 min reflux
Fig. 2 SEM images of PMMA substrates with hybrid coatings; a the edge of the hybrid coating; b the hybrid coating contains a large amount of
pores in size of a few nm
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each virus was applied on glass coverslips, incubated up
to 4 h, titer of recovered virus was determined as speci-
fied in Methods section depending on the virus, and
plotted in the same graph as titer of recovered virus
from untreated glass coverslips (Fig. 6). Very quick initial
virucidal effect of hybrid coatings was achieved against den-
gue virus with 1.1 log10TCID50 reduction after 30 min
exposure, but followed with only additional 1.1 log10TCID50
decline in 4 h. Different course of exposure experiment to
hybrid coatings was observed in the case of herpes simplex
virus. Similarly 1.0 log10TCID50 decrease of HSV-1 titer
was achieved in first 30 min, but complete inactivation was
accomplished after 4 h. Only small decrease (0.7 log10T-
CID50) of influenza virus titer when compared with un-
treated control was achieved after 4 h of exposure to hybrid
coating. Even smaller virucidal effect of hybrid coatings
than against influenza virus was observed against coxsackie
B3 virus, where titers of recovered virus from coated
coverslips were on average only 0.2 log10TCID50 lower than
titers of recovered virus from uncoated coverslips.
Discussion
Development of broad-spectrum antimicrobial surface
coating would represent significant help in the battle
against hospital-acquired infections. We recently reported
new type of hybrid coating containing silver and copper
with strong antibacterial effect against variety of com-
monly occurring bacteria in hospital including Staphylo-
coccus aureus and its methicillin-resistant variant [6]. To
find out the potential antiviral effect, we decided to expose
several different viruses to coated glass coverslips and
poly(methyl methacrylate) wells in 96-well culture plates.
Our general observation is that the properties of pre-
pared hybrid coatings depend more on the sol synthesis
and the subsequent curing method and less on the types
of substrate. This fact was further confirmed by the
examination of chemical and mechanical resistance on
different types of substrate [6, 49]. The thickness of coat-
ings depends on the method of curing as coatings cured
at 150 °C appear to be thinner than those cured at 90 °C
and, than those cured by photopolymerization. Photopo-
lymerized coatings showed worse mechanical properties
than heatpolymerized coatings. These observations need
to be further elucidated. According to SEM images, the
surface of the glasses was homogeneously covered with
the hybrid coatings. The coatings were visible only in
the areas where they were mechanically disturbed. A
very smooth surface without any visible defects was
confirmed also by AFM measurement [49]. We as-
sume that several round-shaped pores were created by
gases that evolved at the substrate-coating boundary.
Pores are clearly visible in Fig. 2 and 3. Nevertheless,
the adhesion of the coatings on glass substrates was
very good in both cases of tested polymerizations.
There were not identified any places with disrupted
adhesion or places containing uncollapsed bubbles
with any of the methods used.
Fig. 3 SEM images of glass substrates with hybrid coatings; a the hybrid coating on the right side of the sample; b the hybrid coating containing


























































Fig. 4 Effect of hybrid coating washings on Vero and HeLa cells
proliferation activity. Vero (black bars) and HeLa (grey bars) cell lines
were exposed to washing of coatings on glass coverslip prepared by
photo- and heat polymerization after 15 sec and 4 h of incubation in
1X PBS. Cell viability after 15 sec of incubation with 1X PBS of uncoated
glass coverslip was set as 100 % for each cell line. Error bars indicate
standard deviations of results from three glass coverslips
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Thorough toxicological analysis of potential adverse ef-
fects is essential for successful implementation of hybrid
coating in health care settings. In general, AgI+, CuII+ and
ZnII+ ions are more toxic than their corresponding nano-
particles Ag, CuO, ZnO [50]. We observed only negligible
cytotoxicity effect on Vero and HeLa cells when exposed
to washings from coated glass coverslips. Moreover, we did
not observe any significant increase in cytotoxicity when
washing the coated glass coverslips immediately or after
four 4 h of incubation. This fact shows that the metal ions
are immobilized in hybrid coating most likely due to ionic
bonding and the leaching of metal ions does not increase
significantly during the 4 h span. It corroborates previous
release study from coated cotton swab when the biggest
decrease of AgI+ and CuII+ amount occurred only after first
washing cycle and after fifty washing cycles there still
remained 40 % of AgI+ and 20 % of CuII+ ions in the coat-
ing [6]. Certain degree of metal ions release from hybrid
coating is necessary otherwise it would impede the viru-
cidal effect. Here, we have shown that this release is not
toxic on two mammalian cell lines but further animal
studies to address sensitization and/or irritation are needed.
The antiviral activities of hybrid coating were initially
tested against HIV-1 on glass coverslips prepared by the
same sol-gel method, which differed only in polymerization
process that was either heat- or photoinitiated. Coatings
prepared by either curing method showed strong anti-HIV-
1 activity after 5 min and further intensified after 20 min.
The bigger decrease in residual HIV-1 activity after 20 min
than after 5 min of exposure of HIV-1 to hybrid coating
containing AgI+, CuII+ and ZnII+ ions supports hypothesis
that these ions have direct inhibition effect on HIV-1
virions. It is generally accepted that silver and copper
ions can exert their biocidal power by directly lysing
membranes or by binding to thiol groups of proteins
[34, 51, 52]. Zinc was shown to have strong antifungal
[53, 54] and antibacterial [55–58] effect. In addition, we
have plenty evidence of zinc virucidal activity against
rhinoviruses [59–61], respiratory syncytial virus [62],
vaccinia virus [63], HSV [64] and HIV-1 [65] but exact
virus inactivation mechanism is mostly unknown. Kim
and coworkers [66] showed that zinc ions can inhibit
protein tyrosine phosphatase albeit to much smaller extent
that copper ions but by different mechanisms not related
to active-site cytosine. Additional proposed mechanisms
for HIV-1 inactivation by zinc include inhibition of HIV-1
protease [67] and inhibition of HIV-1 DNA to RNA tran-
scription [65]. Strong evidence that silver nanoparticles in-
hibit HIV-1 infection by blocking viral entry, particularly
gp120-CD4 interaction provided the work of Lara and co-
workers [25]. They showed in cell-based fusion assay using
Env expressing cells and CD4 expressing cells mixture that
silver nanoparticles blocked cell fusion in dose-dependent
manner. The CD4 binding domain of gp120 has three di-
sulfide bonds that would represent good target to interact
with the virion not only for silver ions but also for copper
ions. From reaction with glutathione in an excess of copper
in the living cells it is assumed that one CuII+ ion can in-
activate 3 thiol groups [34].
Next we coated PMMA 96-well plates and confirmed
quick and increasing anti-HIV-1 effect during prolonged
Table 2 Anti-HIV-1 activity of hybrid coating on glass coverslips
Exposure
time [min]
HIV-1 titer [TCID50/ml] after exposure to uncoated
and coated coverslip and after washing with




Coverslip #1 Coverslip #2 Coverslip #3
Uncoated coverslip 5 3981 3981 3981 - -
20 3981 1000 3981 - -
Coated coverslip by heat polymerization 5 251 1259 1000 79 % <0.001
20 316 251 316 90 % <0.05
Coated coverslip by photopolymerization 5 63 63 63 98 % <0.001
20 0 20 0 99.8 % <0.05
aHIV-1 titer reduction was calculated from average HIV-1 titers from uncoated coverslips set as 100 % minus the quotient between residual average HIV-1 titers
from coated coverslips and average titers from uncoated coverslips expressed in percentage
bOne way analysis of variance test between HIV-1 titers obtained from uncoated coverslips versus coated coverslips at given exposure time




















Fig. 5 Time course of HIV-1 inactivation by hybrid coating on PMMA
wells. Virucidal activity is expressed as HIV-1 titer reduction in percentage.
Error bars indicate standard deviations of three independent experiments
performed in three replicate wells for each time point
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incubation, albeit we achieved on average only 99 % re-
duction in HIV-1 titer after 2 h of exposure to hybrid
coatings. Better results with glass coverslip experiments
can be explained by better adhesion of coatings to glass
surfaces as documented by SEM analysis and primarily
by the fact that HIV-1 droplet on glass coverslip was
covered with another coverslip and thus was more
tightly distributed on larger coated surface.
Finally, to determine the hybrid coating ability to inacti-
vate other viruses, we tested four additional viruses repre-
senting double-stranded DNA virus, negative and positive
sense single-stranded RNA virus and non-enveloped virus.
Interestingly, we observed different time course of virus
titer reduction for these viruses. Positive single-stranded
RNA enveloped dengue virus type 2 had initially quick titer
reduction in first 30 min, but it was not followed by
complete inactivation even after 4 h of exposure. There
are limited data in the literature about anti-dengue activity
of coatings with or without metal ions and nanoparticles.
Dengue virus type 2 infection was not suppressed by
nanoscale silica platelets hybridized with silver nanoparti-
cles but introduction of anionic sodium dodecyl sulfate
efficiently reduced titer almost about three log10TCID50
[68]. Recently, Murugan et al. reported 80 % reduction of
dengue virus type 2 replication by silver nanoparticles at
concentration of 50 μg/ml [69]. Binding of dengue virions
to host cell receptor is mediated through viral envelope
glycoprotein E, which contains 12 strictly conserved
cysteine residues forming six disulfide bonds, followed
by receptor-mediated endocytosis. Several mammalian
cell receptors have been shown to interact with dengue
virions such as sulfated glycosaminoglycans, lectins that
recognize carbohydrates, glycosphingolipid, proteins with
chaperone activity and others [70], but the exact mechan-
ism is still not fully elucidated. Recently, the importance
of lipid composition of host cells and virion membrane
was highlighted [71]. Quick dengue titer reduction in the
first 30 min of our experiment could signal direct effect
on viral membrane and/or disruption of disulfide bonds
by metal ions in our hybrid coatings.
In case of double-stranded DNA HSV-1 we have seen
different course of virus titer reduction than with dengue
virus type 2. Initial one log10TCID50 reduction in titer in
the first half hour was followed by complete inactivation
after 4 h. HSV entry is complex event involving five glyco-
proteins and three alternative cellular receptors with hepa-
ran sulfate being the most important but not essential [72].
Baram-Pinto and coworkers prepared silver nanoparticles
a b
c d
































































Fig. 6 Time course of virucidal activity of hybrid coatings on glass coverslips against a dengue virus, b herpes simplex virus, c influenza virus, and
d coxsackie virus expressed as virus titer (black squares with solid line). In each graph is also depicted time course of virus titer after the exposure
to uncoated glass coverslips (black circles with dashed line). Error bars indicate standard deviations of three independent experiments
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capped by mercaptoethane sulfonate that mimic polysulfo-
nated heparan and showed that these modified nanoprati-
cles block the attachment of the virus to host cells [26].
Moreover, unmodified silver nanoparticles after one hour
preincubation with HSV-2 inhibited subsequent infection
of Vero cells with EC50 = 25 μg/mL [27]. Based on our re-
sults, that HSV-1 is completely inactivated after extended
contact with the coating, we can hypothesize additional
mechanism of HSV-1 inactivation besides direct interaction
with virion particle. One of the possible mechanisms of ac-
tion could be disruption of viral double-stranded DNA
(dsDNA) by metal ions. It has been shown that silver, zinc
and especially copper ions have specific affinity for dsDNA
[32, 34, 73]. This mechanism was postulated for inhibition
of partially double stranded hepatitis B virus by silver nano-
particles, which were able to reduce extracellular hepatitis
B virus DNA by more than 50 % and thus inhibit the for-
mation of intracellular HBV RNA.
The effect of hybrid coating against influenza A
virus lead to only 0.7 log10TCID50 reduction after 4 h
of exposure. Inhibition of influenza A was previously
reported with silver nanoparticles, but the strongest
inhibitory effect was achieved at rather high concentration
of 50 μg/ml of silver nanoparticles [30]. Copper oxide-
based filter reduced influenza A virus titer by 1.77 ± 0.87
log10TCID50 during 40 min filtration [37]. Mechanism for
silver or copper ions anti-influenza activity is unknown.
Recently, functionalized gold nanoparticles with sialic
acid-terminated glycerol dendron were found effective
against influenza virus that was mediated by blocking the
sialic acid receptor on host cell surface, and thus blocking
the fusion step of influenza infection [74].
Hybrid coating exerted only negligible effect on non-
enveloped positive single-stranded RNA coxsackie B3
virus. Similarly, previously reported rhinovirus type 2,
member of the same Picornaviridae family as coxsackie
viruses, exhibited only nonsignificant decrease after
passing through copper oxide-based filter [37]. These
results would support the explanation that our hybrid
coatings with silver, copper and zinc ions act mainly
directly on the virion surface of the enveloped viruses.
Conclusions
In summary, we have characterized virucidal effect of
hybrid coatings containing silver, copper and zinc cations
against different viruses representing double-stranded
DNA virus, negative and positive sense single-stranded
RNA virus and non-enveloped virus. Our experiments
showed good virucidal effect against enveloped viruses es-
pecially HIV and together with previously reported excel-
lent antibacterial effect this hybrid coating has potential to
provide antimicrobial protection on surfaces and materials
in healthcare settings.
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AFM: atomic force microscopy; ATCC: American type culture collection;
BPO: dibenzoylperoxide; DMEM: dulbecco’s modified eagle’s medium; FBS: fetal
bovine serum; FTIR: fourier transform infrared spectroscopy; HAIs: healthcare–
associated infections; HIV-1: human immunodeficiency virus type 1; HSV-
1: herpes simplex virus type 1; IPTI: titanium isopropoxide; MDCK: madin-darby
canine kidney; MMA: methylmethacrylate; ORMOSILs: organically-modified
silicates; PBS: phosphate buffered saline; PMMA: poly(methyl methacrylate);
PMS: phenazine methosulphate; SEM: scanning electron microscope;
TCID50: 50 % tissue culture infective dose; TEOS: tetraethylorthosilicate;
TMOS: tetramethylorthosilicate; TMSPM: 3-(trimethoxysilyl)propyl methacrylate;
TPCK: tosyl phenylalanyl chloromethyl ketone; XTT: 2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide.
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